Kazia to Seek FDA Feedback on Conditional Approval Pathway for Paxalisib in Newly Diagnosed Glioblastoma Read more
Guardant Health and Zephyr AI Partner to Advance Cancer Drug Development Through AI-Driven Insights Read more
FDA Expands Approval of Merck’s WINREVAIR for Pulmonary Arterial Hypertension Following Strong Phase 3 Results Read more
Hemab Therapeutics Secures $157 Million Series C to Advance Breakthrough Treatments for Rare Bleeding Disorders Read more
Lifecore and PolyPeptide Partner to Deliver End-to-End Peptide Drug Development Solutions in the U.S. Read more
GSK Acquires Exclusive Rights to Syndivia’s Next-Generation ADC for Advanced Prostate Cancer Read more
Eli Lilly to Acquire Adverum Biotechnologies in $1.5 Billion Deal to Advance Gene Therapy for Vision Loss Read more